The right choice still depends on your individual health history, which is why speaking with a clinician before starting any GLP-1 is important
Knowing the difference is crucial because it completely changes what treatment approach will work best for you
Plan types and formulary differences Your Cigna plan type is the single biggest factor in determining whether Wegovy is covered
Through these mechanisms, GLP-1RAs promote protein clearance and reduce cellular stress that drives aggregation (Figure 1)
These processes are central to the pathogenesis of a wide range of NDDs, including Alzheimers disease (AD), Parkinsons disease (PD), primary tauopathies (e.g., progressive supranuclear palsy [PSP], corticobasal degeneration [CBD], tau-linked frontotemporal dementia [FTD-tau]), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), synucleinopathies (e.g., Lewy body dementia [LBD] and multiple system atrophy [MSA]), Huntingtons disease (HD) and related polyglutamine (polyQ) diseases (e.g., spinocerebellar ataxias [SCA]), and prion diseases (PrD)